0 CHECKOUT

Prostate Cancer - Pipeline Review, H1 2015

  • ID: 3345020
  • June 2015
  • 1455 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • 4SC AG
  • ATLAB Pharma SAS
  • Eisai Co., Ltd.
  • Immunomedics, Inc.
  • Oasmia Pharmaceutical AB
  • Rigontec GmbH
  • MORE

Prostate Cancer - Pipeline Review, H1 2015

Summary

the, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Prostate Cancer and special features on late-stage and discontinued projects.

the report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 4SC AG
  • ATLAB Pharma SAS
  • Eisai Co., Ltd.
  • Immunomedics, Inc.
  • Oasmia Pharmaceutical AB
  • Rigontec GmbH
  • MORE

Introduction
Prostate Cancer Overview
Therapeutics Development
Prostate Cancer – Therapeutics under Development by Companies
Prostate Cancer – Therapeutics under Investigation by Universities/Institutes
Prostate Cancer – Pipeline Products Glance
Prostate Cancer – Products under Development by Companies
Prostate Cancer – Products under Investigation by Universities/Institutes
Prostate Cancer – Companies Involved in Therapeutics Development
Prostate Cancer – Therapeutics Assessment
Drug Profiles
Prostate Cancer – Recent Pipeline Updates
Prostate Cancer – Dormant Projects
Prostate Cancer – Discontinued Products
Prostate Cancer – Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Prostate Cancer, H1 2015
Number of Products under Development for Prostate Cancer – Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Development by Companies, H1 2015 (Contd..7)
Number of Products under Development by Companies, H1 2015 (Contd..8)
Number of Products under Development by Companies, H1 2015 (Contd..9)
Number of Products under Development by Companies, H1 2015 (Contd..10)
Number of Products under Development by Companies, H1 2015 (Contd..11)
Number of Products under Development by Companies, H1 2015 (Contd..12)
Number of Products under Development by Companies, H1 2015 (Contd..13)
Number of Products under Development by Companies, H1 2015 (Contd..14)
Number of Products under Development by Companies, H1 2015 (Contd..15)
Number of Products under Development by Companies, H1 2015 (Contd..16)
Number of Products under Development by Companies, H1 2015 (Contd..17)
Number of Products under Development by Companies, H1 2015 (Contd..18)
Number of Products under Development by Companies, H1 2015 (Contd..19)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..4)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Development by Companies, H1 2015 (Contd..9)
Products under Development by Companies, H1 2015 (Contd..10)
Products under Development by Companies, H1 2015 (Contd..11)
Products under Development by Companies, H1 2015 (Contd..12)
Products under Development by Companies, H1 2015 (Contd..13)
Products under Development by Companies, H1 2015 (Contd..14)
Products under Development by Companies, H1 2015 (Contd..15)
Products under Development by Companies, H1 2015 (Contd..16)
Products under Development by Companies, H1 2015 (Contd..17)
Products under Development by Companies, H1 2015 (Contd..18)
Products under Development by Companies, H1 2015 (Contd..19)
Products under Development by Companies, H1 2015 (Contd..20)
Products under Development by Companies, H1 2015 (Contd..21)
Products under Development by Companies, H1 2015 (Contd..22)
Products under Development by Companies, H1 2015 (Contd..23)
Products under Development by Companies, H1 2015 (Contd..24)
Products under Development by Companies, H1 2015 (Contd..25)
Products under Development by Companies, H1 2015 (Contd..26)
Products under Development by Companies, H1 2015 (Contd..27)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..4)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..5)
Prostate Cancer – Pipeline by 4SC AG, H1 2015
Prostate Cancer – Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2015
Prostate Cancer – Pipeline by AB Science, H1 2015
Prostate Cancer – Pipeline by AbbVie Inc., H1 2015
Prostate Cancer – Pipeline by Acino Pharma AG, H1 2015
Prostate Cancer – Pipeline by Actinium Pharmaceuticals, Inc., H1 2015
Prostate Cancer – Pipeline by Adamis Pharmaceuticals Corporation, H1 2015
Prostate Cancer – Pipeline by ADC Therapeutics Sarl, H1 2015
Prostate Cancer – Pipeline by Addex Therapeutics Ltd, H1 2015
Prostate Cancer – Pipeline by Aduro BioTech, Inc., H1 2015
Prostate Cancer – Pipeline by Advanced Cancer Therapeutics, H1 2015
Prostate Cancer – Pipeline by Advantagene, Inc., H1 2015
Prostate Cancer – Pipeline by Advaxis, Inc., H1 2015
Prostate Cancer – Pipeline by Aeterna Zentaris Inc., H1 2015
Prostate Cancer – Pipeline by Aileron Therapeutics, Inc., H1 2015
Prostate Cancer – Pipeline by Akshaya Bio Inc., H1 2015
Prostate Cancer – Pipeline by Alchemia Limited, H1 2015
Prostate Cancer – Pipeline by Alethia Biotherapeutics Inc., H1 2015
Prostate Cancer – Pipeline by Almac Discovery Limited, H1 2015
Prostate Cancer – Pipeline by Ambrx, Inc., H1 2015
Prostate Cancer – Pipeline by Amgen Inc., H1 2015
Prostate Cancer – Pipeline by Amorfix Life Sciences Ltd., H1 2015
Prostate Cancer – Pipeline by Anavex Life Sciences Corp., H1 2015
Prostate Cancer – Pipeline by AndroScience Corporation, H1 2015
Prostate Cancer – Pipeline by Angion Biomedica Corp., H1 2015
Prostate Cancer – Pipeline by AntiCancer, Inc., H1 2015
Prostate Cancer – Pipeline by Antigen Express, Inc., H1 2015
Prostate Cancer – Pipeline by Antisense Therapeutics Limited, H1 2015
Prostate Cancer – Pipeline by Aphios Corporation, H1 2015
Prostate Cancer – Pipeline by APIM Therapeutics AS, H1 2015
Prostate Cancer – Pipeline by Aptose Biosciences Inc., H1 2015
Prostate Cancer – Pipeline by Armour Therapeutics Inc., H1 2015
Prostate Cancer – Pipeline by Arno Therapeutics, Inc., H1 2015
Prostate Cancer – Pipeline by ArQule, Inc., H1 2015
Prostate Cancer – Pipeline by Arrien Pharmaceuticals, LLC, H1 2015
Prostate Cancer – Pipeline by Arrowhead Research Corporation, H1 2015
Prostate Cancer – Pipeline by Ascenta Therapeutics, Inc., H1 2015
Prostate Cancer – Pipeline by Astellas Pharma Inc., H1 2015
Prostate Cancer – Pipeline by Astex Pharmaceuticals, Inc., H1 2015
Prostate Cancer – Pipeline by AstraZeneca Plc, H1 2015
Prostate Cancer – Pipeline by ATLAB Pharma SAS, H1 2015
Prostate Cancer – Pipeline by Avipep Pty Ltd, H1 2015
Prostate Cancer – Pipeline by Axelar AB, H1 2015
Prostate Cancer – Pipeline by Azaya Therapeutics Incorporated, H1 2015
Prostate Cancer – Pipeline by Bavarian Nordic A/S, H1 2015
Prostate Cancer – Pipeline by Bayer AG, H1 2015
Prostate Cancer – Pipeline by Bellicum Pharmaceuticals, Inc., H1 2015
Prostate Cancer – Pipeline by Beta Pharma, Inc., H1 2015
Prostate Cancer – Pipeline by BHR Pharma, LLC, H1 2015
Prostate Cancer – Pipeline by BIND Therapeutics, Inc., H1 2015
Prostate Cancer – Pipeline by Bio-Cancer Treatment International Limited, H1 2015
Prostate Cancer – Pipeline by Bio-Path Holdings, Inc., H1 2015
Prostate Cancer – Pipeline by BioMarin Pharmaceutical Inc., H1 2015
Prostate Cancer – Pipeline by Bionature E.A. Ltd., H1 2015
Prostate Cancer – Pipeline by Bionomics Limited, H1 2015
Prostate Cancer – Pipeline by Biotest AG, H1 2015
Prostate Cancer – Pipeline by Biscayne Pharmaceuticals, Inc., H1 2015
Prostate Cancer – Pipeline by Boehringer Ingelheim GmbH, H1 2015
Prostate Cancer – Pipeline by Bristol-Myers Squibb Company, H1 2015
Prostate Cancer – Pipeline by Camurus AB, H1 2015
Prostate Cancer – Pipeline by Celgene Corporation, H1 2015
Prostate Cancer – Pipeline by CellCentric Ltd, H1 2015
Prostate Cancer – Pipeline by Celldex Therapeutics, Inc., H1 2015
Prostate Cancer – Pipeline by Cellectar Biosciences, Inc., H1 2015
Prostate Cancer – Pipeline by Champions Oncology, Inc., H1 2015
Prostate Cancer – Pipeline by Cimab S.A., H1 2015
Prostate Cancer – Pipeline by Colby Pharmaceutical Company, H1 2015
Prostate Cancer – Pipeline by Cold Genesys, Inc., H1 2015
Prostate Cancer – Pipeline by Corcept Therapeutics Incorporated, H1 2015
Prostate Cancer – Pipeline by Crescendo Biologics Limited, H1 2015
Prostate Cancer – Pipeline by CureTech Ltd., H1 2015
Prostate Cancer – Pipeline by CureVac GmbH, H1 2015
Prostate Cancer – Pipeline by CytoVac A/S, H1 2015
Prostate Cancer – Pipeline by CZ BioMed Corp, H1 2015
Prostate Cancer – Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Prostate Cancer – Pipeline by DEKK-TEC, Inc., H1 2015
Prostate Cancer – Pipeline by DexTech Medical AB, H1 2015
Prostate Cancer – Pipeline by DiaMedica Inc., H1 2015
Prostate Cancer – Pipeline by Dongkook Pharmaceutical Co., Ltd., H1 2015
Prostate Cancer – Pipeline by DormaTarg, Inc., H1 2015
Prostate Cancer – Pipeline by Eisai Co., Ltd., H1 2015
Prostate Cancer – Pipeline by Eli Lilly and Company, H1 2015
Prostate Cancer – Pipeline by Emergent BioSolutions Inc., H1 2015
Prostate Cancer – Pipeline by Enceladus Pharmaceuticals BV, H1 2015
Prostate Cancer – Pipeline by Endo Pharmaceuticals Inc., H1 2015
Prostate Cancer – Pipeline by EndoCeutics, Inc., H1 2015
Prostate Cancer – Pipeline by Endocyte, Inc., H1 2015
Prostate Cancer – Pipeline by EntreChem, S.L., H1 2015
Prostate Cancer – Pipeline by Errant Gene Therapeutics, LLC, H1 2015
Prostate Cancer – Pipeline by Esperance Pharmaceuticals, Inc., H1 2015
Prostate Cancer – Pipeline by Evgen Limited, H1 2015
Prostate Cancer – Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Prostate Cancer – Pipeline by Ferring International Center S.A., H1 2015
Prostate Cancer – Pipeline by Foresee Pharmaceuticals, LLC, H1 2015
Prostate Cancer – Pipeline by Fortress Biotech, Inc., H1 2015
Prostate Cancer – Pipeline by Fujifilm Corporation, H1 2015
Prostate Cancer – Pipeline by Galectin Therapeutics, Inc., H1 2015
Prostate Cancer – Pipeline by Galileo Research s.r.l., H1 2015
Prostate Cancer – Pipeline by Genelux Corporation, H1 2015
Prostate Cancer – Pipeline by Genentech, Inc., H1 2015
Prostate Cancer – Pipeline by Genmab A/S, H1 2015
Prostate Cancer – Pipeline by GenSpera, Inc., H1 2015
Prostate Cancer – Pipeline by Glactone Pharma AB, H1 2015
Prostate Cancer – Pipeline by GlaxoSmithKline Plc, H1 2015
Prostate Cancer – Pipeline by GlycoMimetics, Inc., H1 2015
Prostate Cancer – Pipeline by GP Pharm, S.A., H1 2015

List of Figures
Number of Products under Development for Prostate Cancer, H1 2015
Number of Products under Development for Prostate Cancer – Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

4SC AG
A. Menarini Industrie Farmaceutiche Riunite Srl
AB Science
AbbVie Inc.
Acino Pharma AG
Actinium Pharmaceuticals, Inc.
Adamis Pharmaceuticals Corporation
ADC Therapeutics Sarl
Addex Therapeutics Ltd
Aduro BioTech, Inc.
Advanced Cancer Therapeutics
Advantagene, Inc.
Advaxis, Inc.
Aeterna Zentaris Inc.
Aileron Therapeutics, Inc.
Akshaya Bio Inc.
Alchemia Limited
Alethia Biotherapeutics Inc.
Almac Discovery Limited
Ambrx, Inc.
Amgen Inc.
Amorfix Life Sciences Ltd.
Anavex Life Sciences Corp.
AndroScience Corporation
Angion Biomedica Corp.
AntiCancer, Inc.
Antigen Express, Inc.
Antisense Therapeutics Limited
Aphios Corporation
APIM Therapeutics AS
Aptose Biosciences Inc.
Armour Therapeutics Inc.
Arno Therapeutics, Inc.
ArQule, Inc.
Arrien Pharmaceuticals, LLC
Arrowhead Research Corporation
Ascenta Therapeutics, Inc.
Astellas Pharma Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
ATLAB Pharma SAS
Avipep Pty Ltd
Axelar AB
Azaya Therapeutics Incorporated
Bavarian Nordic A/S
Bayer AG
Bellicum Pharmaceuticals, Inc.
Beta Pharma, Inc.
BHR Pharma, LLC
BIND Therapeutics, Inc.
Bio-Cancer Treatment International Limited
Bio-Path Holdings, Inc.
BioMarin Pharmaceutical Inc.
Bionature E.A. Ltd.
Bionomics Limited
Biotest AG
Biscayne Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Camurus AB
Celgene Corporation
CellCentric Ltd
Celldex Therapeutics, Inc.
Cellectar Biosciences, Inc.
Champions Oncology, Inc.
Cimab S.A.
Colby Pharmaceutical Company
Cold Genesys, Inc.
Corcept Therapeutics Incorporated
Crescendo Biologics Limited
CureTech Ltd.
CureVac GmbH
CytoVac A/S
CZ BioMed Corp
Daiichi Sankyo Company, Limited
DEKK-TEC, Inc.
DexTech Medical AB
DiaMedica Inc.
DormaTarg, Inc.
Eisai Co., Ltd.
Eli Lilly and Company
Emergent BioSolutions Inc.
Enceladus Pharmaceuticals BV
Endo Pharmaceuticals Inc.
EndoCeutics, Inc.
Endocyte, Inc.
EntreChem, S.L.
Errant Gene Therapeutics, LLC
Esperance Pharmaceuticals, Inc.
Evgen Limited
F. Hoffmann-La Roche Ltd.
Ferring International Center S.A.
Foresee Pharmaceuticals, LLC
Fortress Biotech, Inc.
Fujifilm Corporation
Galectin Therapeutics, Inc.
Galileo Research s.r.l.
Genelux Corporation
Genentech, Inc.
Genmab A/S
GenSpera, Inc.
Glactone Pharma AB
GlaxoSmithKline Plc
GlycoMimetics, Inc.
GP Pharm, S.A.
GTx, Inc.
Humanetics Corporation
Hybrigenics S.A.
IC-MedTech, Inc.
IGF Oncology, LLC.
Ignyta, Inc.
Ildong Pharmaceutical Co., Ltd.
Immunocore Limited
ImmunoFrontier, Inc.
Immunomedics, Inc.
Immunovaccine, Inc.
Innate Immunotherapeutics Limited
Inovio Pharmaceuticals, Inc.
Io Therapeutics, Inc.
Ipsen S.A.
IRX Therapeutics, Inc.
Isis Pharmaceuticals, Inc.
Johnson & Johnson
Kadmon Corporation, LLC
Kancera AB
Karyopharm Therapeutics, Inc.
Komipharm International Co., Ltd.
Kyowa Hakko Kirin Co., Ltd.
Lidds AB
Luye Pharma Group Ltd.
MacroGenics, Inc.
Mebiopharm Co., Ltd.
Medeia Therapeutics Ltd.
MediaPharma s.r.l.
MediGene AG
MedImmune, LLC
Mediolanum farmaceutici S.p.A.
Medivation, Inc.
MEI Pharma, Inc.
Merck & Co., Inc.
Merck KGaA
Merrion Pharmaceuticals Plc
Millennium Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
MolMed S.p.A.
Morphotek, Inc.
Nanobiotix
Natco Pharma Limited
NewLink Genetics Corporation
Novartis AG
Novogen Limited
Nymox Pharmaceutical Corporation
Oasmia Pharmaceutical AB
Omeros Corporation
Omnitura Therapeutics Inc.
Oncbiomune, L.L.C.
Oncodrone BV
Oncogenex Pharmaceuticals, Inc.
Oncology Research International Limited
Oncolytics Biotech Inc.
OncoMax
OncoNOx ApS
Oncothyreon Inc.
Oncovir, Inc.
OncoVista Innovative Therapies, Inc.
Onyx Pharmaceuticals, Inc.
ORCA Therapeutics B.V.
Orion Oyj
Orphagen Pharmaceuticals, Inc.
Otsuka Holdings Co., Ltd.
OXiGENE, Inc.
Panacela Labs, Inc.
Pantarhei Bioscience BV
Pfizer Inc.
Pharmedartis GmbH
Pharmicell Co., Ltd.
Pharminox Limited
Philogen S.p.A.
Polaris Pharmaceuticals, Inc.
Polyplus-transfection SA
Prima BioMed Ltd.
Progenics Pharmaceuticals, Inc.
ProMetic Life Sciences Inc.
Provenance Biopharmaceuticals Corp.
PSites Pharma GmbH
Qu Biologics Inc.
Quest PharmaTech Inc.
RedHill Biopharma Ltd.
RestorGenex Corporation
Rexahn Pharmaceuticals, Inc.
Rigontec GmbH
Sanofi
Sareum Holdings Plc
SEEK Group
Serometrix, LLC
Shenogen Pharma Group Ltd.
Solasia Pharma K.K.
Sophiris Bio, Inc.
Soricimed Biopharma Inc.
Sotio a.s.
Sun Pharma Advanced Research Company Ltd.
Sunesis Pharmaceuticals, Inc.
Supratek Pharma Inc.
Synta Pharmaceuticals Corp.
Tactic Pharma, LLC
Takeda Pharmaceutical Company Limited
Teikoku Pharma USA, Inc.
Teva Pharmaceutical Industries Limited
Theravectys S.A.
TheRyte Limited
Tokai Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc.
Treat U, S.A.
TVAX Biomedical, Inc.
Ultimovacs AS
Vaccibody AS
ValiRx Plc
Vasgen Limited
Vaxeal Holding SA
Vaxon Biotech
Vicore Pharma AB
Vicus Therapeutics, LLC
Viralytics Ltd.
ViraTherapeutics GmbH
Viventia Biotechnologies Inc.
vTv Therapeutics Inc.
WntResearch AB
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zymeworks Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Johnson & Johnson Services, Inc.
  • Sanofi S.A.
  • Astellas Pharma, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Astrazeneca PLC
  • Emergent BioSolutions, Inc.